Transposase-based genomic analysis
The methods and reagents are provided for barcoding and analysis of DNA samples using partition (e.g., droplet) technology while avoiding performing amplification in droplets.
1. A method of barcoding DNA, the method comprising
introducing oligonucleotide adaptors randomly into DNA by contacting the DNA with a transposase loaded with the oligonucleotide adaptors,
wherein the oligonucleotide adaptors comprise a 3′ single stranded portion and a double stranded portion, with a first oligonucleotide having a 3′ end and a 5′ end and being a strand of the double-stranded portion and a second oligonucleotide comprising the single-stranded portion and a complementary strand of the double stranded portion, and
wherein the transposase introduces double-stranded breaks into the DNA, wherein each double-stranded break forms two DNA ends and the transposase ligates the first oligonucleotide to one strand of each DNA end, to form DNA fragments comprising the oligonucleotide adaptors at both ends;
forming droplets, wherein the droplets contain the DNA fragments and a first oligonucleotide primer having a bead-specific barcode sequence, wherein the first oligonucleotide primer is linked to a bead and comprises a free 3′ end that is complementary to the 3′ single stranded portion of the oligonucleotide adaptor[ ];
hybridizing the 3′ end of the first oligonucleotide primer, which is optionally released from the bead, to the 3′ single stranded portion of the oligonucleotide adaptor;
combining contents of the droplets to form a reaction mixture;
contacting the reaction mixture with a ligase, thereby ligating the first oligonucleotide primer to the 5′ end of the first oligonucleotide ligated to the DNA ends, thereby generating barcoded DNA fragments.
2. The method of claim 1 , further comprising amplifying the barcoded fragments.
3. The method of claim 2 , wherein the amplifying comprises polymerase chain reaction.
4. The method of claim 1 , comprising stripping the transposase from the DNA before the hybridizing.
5. The method of claim 4 , wherein the stripping occurs in the droplets.
6. The method of claim 4 , wherein the DNA is in a nucleus and the stripping occurs before the forming of the droplets.
7. The method of claim 1 , comprising cleaving the oligonucleotide primer from beads before the hybridizing.
8. The method of claim 1 , wherein the transposase is loaded with two different adaptor oligonucleotides having the same double stranded portion and different single stranded portions.
9. The method of claim 1 , wherein the transposase is loaded with two identical adaptor oligonucleotides.
10. The method of claim 1 , wherein the first oligonucleotide primer comprises a 5′ PCR handle sequence.
11. The method of claim 10 , wherein the droplets further comprise a second oligonucleotide primer and wherein the second oligonucleotide primer comprises a 5′ PCR handle.
12. The method of claim 1 , wherein the single-stranded portion of the second oligonucleotide comprises:
i. a 3′ end sequence less than 50% complementary to the first oligonucleotide primer; and
ii. a middle sequence that is at least 50% complementary to the free 3′ end of the first oligonucleotide primer.
13. The method of claim 1 , wherein the DNA comprises DNA-bound proteins during the introducing.
14. The method of claim 13 , further comprising removing the DNA-bound proteins from the DNA following the combining.
15. The method of claim 13 , further comprising removing the DNA-bound proteins from the DNA before the combining.
16. The method of claim 1 , wherein the forming maintains contiguity of the DNA fragments compared to DNA from a cell.
17. The method of claim 1 , wherein the DNA is purified following the combining and before the contacting.
18. The method of claim 1 , further comprising during the combining, mixing the contents of the droplets with a competitor oligonucleotide comprising the single-stranded portion, which hybridizes to 3′ ends of unbound copies of the first oligonucleotide primer, thereby preventing de novo binding of unbound DNA fragments after the combining.
19. The method of claim 1 , further comprising during the combining, mixing the contents of the droplets with a competitor oligonucleotide comprising the single-stranded portion, which hybridizes to 3′ ends of unbound copies of the oligonucleotide adaptors, thereby preventing de novo binding of unbound DNA fragments after the combining.
20. The method of claim 19 , wherein the competitor oligonucleotides comprise 3′ ends that are not extendable by a polymerase.